department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Brilinta · pharmadog

pharmadog
drugs
Brilinta

drug

patient view →

Brilinta

Marketedupdated 2mo ago

by AstraZeneca Pharmaceuticals LP

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Brilinta

generic

ticagrelor

indication

Acute Coronary Syndrome

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 4

tagApproval40 co-mentions · 20 sources
tagSmall Molecule20 co-mentions · 20 sources
drugTICAGRELOR20 co-mentions · 20 sources
companyMankind Pharma Ltd1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying Brilinta

phase3Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosisactive not recruitingn=1,683
phase1Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination.completedn=24
phase1Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteersnot yet recruitingn=16
phase3DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injurycompletedn=220
phase3TADCLOT- a Double Blind Randomized Controlled Trialcompletedn=2,200
phase1A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjectscompletedn=77
phase1A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participantscompletedn=28
phase4Ticagrelor With and Without Aspirin in Patients With Diabetes Mellituscompletedn=105

more trials →